Literature reviews  >  Articles for review > Young et al. Evaluation of ligase chain reaction...

 

About SDI
Mission
Diagnostic
Priorities
Workplan
Activities
Newsletters
Grants
Publications
Journal articles
Guidelines
Manuals
Reports
Literature reviews
Contact us

The ligase chain reaction assay is a very sensitive method for detecting N. gonorrhoeae in rectal and pharyngeal samples.

Evaluation of ligase chain reaction for the non-cultural detection of rectal and pharyngeal gonorrhea in men who have sex with men.
Young H, Manavi K, McMillan A.
Sexually Transmitted Infections 2003;79:484-486.

 

Summary:

Question
How well does a nucleic acid amplification test (ligase chain reaction (LCR)) compare with culture for the detection of N. gonorrhoeae in rectal and pharyngeal specimens from men who have sex with men (MSM)?

Design
This paper describes a prospective, double-blinded investigation to assess the performance of the LCR test for detecting rectal and pharyngeal gonorrhea, as determined by a gold standard based on both LCR and culture, in MSM attending a genitourinary medicine clinic.

Participants
Two hundred fifty-one consecutive MSM attending a clinic of genitourinary medicine for full screening for sexually transmitted infections were tested.

Description of Tests and Diagnostic Standard
Duplicate rectal swabs were collected from the distal 3 cm of the anal canal. Duplicate throat swabs were collected from the tonsillar area and posterior pharyngeal wall. One swab from each site was immediately rolled over MNYC medium and incubated at 37oC in CO2 enriched atmosphere. Cultures were examined after 24 and 48 h. Gram-negative diplococci from oxidase-positive colonies were confirmed as N. gonorrhoeae by the Phadebact Monoclonal GC test and by rapid carbohydrate utilization tests. The second swab from each site was placed in LCR transport medium and stored at -20oC. The specimens were processed and tested for N. gonorrhoeae DNA using the ligase chain reaction assay (Abbott Laboratories) according to the manufacturer's protocol. Specimens with LCR positive results not corroborated by culture were tested by a second LCR reaction that used probes based on the N. gonorrhoeae pilin gene. True positive specimens were defined as those with positive culture results regardless of the LCR results or, if culture negative, two positive LCR results.

Main Outcome Measures
The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of culture and LCR for the diagnosis of rectal and pharyngeal N. gonorrhoeae infections were determined.

Main Results
The prevalence of N. gonorrhoeae among 251 duplicate throat swabs from MSM was 12.7% (32 of 251) and 6.0% (15 of 251) by LCR and culture, respectively. LCR and culture were concordant in 230 (91.6%) specimens. The prevalence of N. gonorrhoeae detected by LCR was significantly higher than by culture (p = 0.005). The prevalence of N. gonorrhoeae among 227 duplicate rectal swabs was 7.0% (16 of 227) and 4.0% (9 of 227) by LCR and culture, respectively. LCR and culture were concordant in 219 (96.5%) specimens. The performances of LCR and culture for the diagnosis of rectal and pharyngeal gonorrhea in MSM, as defined by the gold standard described above, are shown in the table.

Authors' Conclusions
Routine screening for N. gonorrhoeae infection of rectal and pharyngeal sites by a nucleic acid amplification test (NAAT) method should be considered. However, because false positive reactions can occur with NAATs, it is prudent to consider the initial result as a "presumptive" positive and to confirm the findings with a second NAAT based on a different target gen.

Source of funding: Not given

For correspondence: Hugh Young, Scottish Neisseria gonorrhoeae Reference Laboratory, Directorate of Medical Microbiology, The Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK. E-mail address: hugh.young@luht.scot.nhs.uk

   

about SDI | newsletters | grants | publications | literature reviews

WHO Home - WHO Search - TDR Home - SDI Home - SDI Contact us
(c) WHO/OMS 2001